Answer
In adults and children aged 12 years and older requiring parenteral therapy, intravenous clarithromycin treats susceptible-organism infections: acute exacerbation of chronic bronchitis, community-acquired pneumonia, adequately diagnosed acute bacterial sinusitis, streptococcal pharyngitis and tonsillitis, and skin and soft tissue infections, considering official antibacterial-use guidance.
Sources for this answer
- Clarithromycin 500 mg powder for concentrate for solution for infusionhameln pharma ltd · emc · SmPC §4.1 Therapeutic Indications · Version 16Document updated
Sources checked